Structures by: Samsodien H.
Total: 8
None
C19H28N2O7S2,0.5(H2O1)
Journal of Pharmaceutical Sciences (2015) 104, 3418-3425
a=9.4990(13)Å b=10.5848(15)Å c=43.643(6)Å
α=90.00° β=90.00° γ=90.00°
2-methoxyestradiol chloroform solvate 1:2
C19H26O3,2(C1H1Cl3)
Journal of Pharmaceutical Sciences (2015) 104, 3418-3425
a=6.3150(2)Å b=9.3352(3)Å c=11.1622(5)Å
α=104.386(2)° β=95.464(2)° γ=107.774(2)°
2-methoxyestradiol
C19H26O3
Journal of Pharmaceutical Sciences (2015) 104, 3418-3425
a=6.2540(2)Å b=11.2919(3)Å c=11.5524(4)Å
α=90.00° β=97.3550(10)° γ=90.00°
Nevirapine-glutaric acid 1:1 co-crystal
C15H14N4O,C5H8O4
CrystEngComm (2012) 14, 7 2541
a=7.363(4)Å b=12.292(6)Å c=12.305(6)Å
α=118.571(8)° β=90.144(9)° γ=98.023(8)°
Nevirapine-maleic acid 1:1 co-crystal
C15H14N4O,C4H4O4
CrystEngComm (2012) 14, 7 2541
a=7.4001(5)Å b=10.4599(7)Å c=23.2561(16)Å
α=90.00° β=98.9680(10)° γ=90.00°
Nevirapine-rac-tartaric acid 1:1 co-crystal
C15H14N4O,C4H6O6
CrystEngComm (2012) 14, 7 2541
a=9.877(2)Å b=19.286(4)Å c=9.6971(19)Å
α=90.00° β=90.66(3)° γ=90.00°
Nevirapine-saccharin 2:1 cocrystal
2(C15H14N4O),C7H5NO3S
CrystEngComm (2012) 14, 7 2541
a=9.5649(5)Å b=13.8069(7)Å c=13.8726(7)Å
α=64.090(3)° β=79.292(2)° γ=82.686(2)°
Nevirapine-salicylic acid 2:1 co-crystal
2(C15H14N4O),C7H6O3
CrystEngComm (2012) 14, 7 2541
a=11.1549(14)Å b=12.6194(15)Å c=13.4644(16)Å
α=113.374(2)° β=99.133(2)° γ=107.324(2)°